Zolimomab aritox
Zolimomab Aritox
Zolimomab Aritox (pronunciation: zo-li-mo-mab a-ri-tox) is a type of monoclonal antibody used in the field of oncology for the treatment of certain types of cancer.
Etymology
The name "Zolimomab Aritox" is derived from the International Nonproprietary Names (INN), where "zu" refers to humanized, "limo" refers to the immune system, "mab" is indicative of a monoclonal antibody, and "aritox" is a unique stem used for the specific drug.
Usage
Zolimomab Aritox is used in the treatment of certain types of cancer. It works by binding to specific proteins on the surface of cancer cells, thereby inhibiting their growth and proliferation.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
See Also
External links
- Medical encyclopedia article on Zolimomab aritox
- Wikipedia's article - Zolimomab aritox
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski